Cargando…
Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19
Severe mortality due to the COVID-19 pandemic resulted from the lack of effective treatment. Although COVID-19 vaccines are available, their side effects have become a challenge for clinical use in patients with chronic diseases, especially cancer patients. In the current report, we applied network...
Autores principales: | Qin, Jingru, Guo, Chao, Yang, Lu, Liang, Xiao, Jiao, Aijun, Lai, Keng Po, Yang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809988/ https://www.ncbi.nlm.nih.gov/pubmed/34931923 http://dx.doi.org/10.1080/21655979.2021.2005876 |
Ejemplares similares
-
Bioinformatics and In Silico Findings Uncover Bio-Targets of Calycosin Against Heart Failure and Diabetes Mellitus
por: Xu, Hongyuan, et al.
Publicado: (2022) -
Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A
por: Luo, Qing, et al.
Publicado: (2019) -
Microbial Glycosylation of Daidzein, Genistein and Biochanin A: Two New Glucosides of Biochanin A
por: Sordon, Sandra, et al.
Publicado: (2017) -
Perspectives Regarding the Role of Biochanin A in Humans
por: Yu, Chen, et al.
Publicado: (2019) -
Chemical and Biological Properties of Biochanin A and Its Pharmaceutical Applications
por: Feng, Zhen-Jie, et al.
Publicado: (2023)